Skip to content

Clinical trials

Phase 3 Musculoskeletal Diseases trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Musculoskeletal Diseases Phase: Phase 3 Country / region: Australia Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20122
20131
20141
20153
20164
20175
20181
20191
20211
20232
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Active, not recruiting4
Terminated3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie8
BioMarin Pharmaceutical3
PTC Therapeutics3
Amgen2
Catabasis Pharmaceuticals2
Avidity Biosciences, Inc.1
Calcilytix Therapeutics, Inc., a BridgeBio company1
Kyntra Bio1
Mesoblast, Ltd.1
QED Therapeutics, a BridgeBio company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Musculoskeletal Diseases24
Genetic Diseases, Inborn9
Arthritis8
Joint Diseases8
Bone Diseases7
Muscular Dystrophies7
Muscular Dystrophy, Duchenne7
Neuromuscular Diseases7
Arthritis, Rheumatoid6
Muscular Diseases6

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.